Campbell Capital Management Inc. Makes New Investment in GE HealthCare Technologies Inc. $GEHC

Campbell Capital Management Inc. bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 80,500 shares of the company’s stock, valued at approximately $6,046,000. GE HealthCare Technologies comprises 2.3% of Campbell Capital Management Inc.’s portfolio, making the stock its 14th biggest holding.

Other hedge funds also recently made changes to their positions in the company. True North Advisors LLC increased its position in GE HealthCare Technologies by 2.0% during the 3rd quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock worth $525,000 after purchasing an additional 139 shares in the last quarter. Klingman & Associates LLC boosted its position in GE HealthCare Technologies by 4.0% in the third quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock valued at $273,000 after buying an additional 139 shares in the last quarter. Colonial Trust Advisors grew its stake in shares of GE HealthCare Technologies by 11.1% during the third quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after buying an additional 139 shares during the last quarter. Norinchukin Bank The grew its stake in shares of GE HealthCare Technologies by 0.4% during the third quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock worth $2,922,000 after buying an additional 149 shares during the last quarter. Finally, Exchange Traded Concepts LLC increased its holdings in shares of GE HealthCare Technologies by 1.3% during the third quarter. Exchange Traded Concepts LLC now owns 11,490 shares of the company’s stock worth $863,000 after buying an additional 150 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Up 0.2%

Shares of NASDAQ GEHC opened at $72.34 on Wednesday. The firm has a 50 day moving average price of $80.24 and a two-hundred day moving average price of $78.52. The stock has a market cap of $32.97 billion, a P/E ratio of 15.86, a price-to-earnings-growth ratio of 1.59 and a beta of 1.03. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $89.77. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. GE HealthCare Technologies’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on GEHC shares. Wells Fargo & Company increased their price target on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Citigroup lowered their target price on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a report on Wednesday, March 11th. The Goldman Sachs Group reiterated a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Wall Street Zen raised GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Finally, Bank of America boosted their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a report on Monday, January 5th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $92.17.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.